PlainRecalls
FDA Drug Low Class III Terminated

PREMARIN (conjugated estrogen tablets, USP) 1.25 mg, 1000- count bottle, Rx only, Distributed by: Wyeth Pharmaceuticals Inc. A subsidiary of Pfizer Inc. Philadelphia, PA 19101, NDC 0046-1104-91

Reported: October 5, 2016 Initiated: September 15, 2016 #D-1528-2016

Product Description

PREMARIN (conjugated estrogen tablets, USP) 1.25 mg, 1000- count bottle, Rx only, Distributed by: Wyeth Pharmaceuticals Inc. A subsidiary of Pfizer Inc. Philadelphia, PA 19101, NDC 0046-1104-91

Reason for Recall

Labeling: Incorrect or Missing Lot and/or Exp Date: Bottles were incorrectly labeled with an expiry date of 11/17; the correct date is 09/17.

Details

Recalling Firm
Pfizer Inc.
Units Affected
1,316 bottles (1,316,000 tablets)
Distribution
Nationwide
Location
New York, NY

Frequently Asked Questions

What product was recalled?
PREMARIN (conjugated estrogen tablets, USP) 1.25 mg, 1000- count bottle, Rx only, Distributed by: Wyeth Pharmaceuticals Inc. A subsidiary of Pfizer Inc. Philadelphia, PA 19101, NDC 0046-1104-91. Recalled by Pfizer Inc.. Units affected: 1,316 bottles (1,316,000 tablets).
Why was this product recalled?
Labeling: Incorrect or Missing Lot and/or Exp Date: Bottles were incorrectly labeled with an expiry date of 11/17; the correct date is 09/17.
Which agency issued this recall?
This recall was issued by the FDA Drug on October 5, 2016. Severity: Low. Recall number: D-1528-2016.